AJP - GI AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 289: G571-G578, 2005. First published April 28, 2005; doi:10.1152/ajpgi.00537.2004
0193-1857/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/3/G571    most recent
00537.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brun, P.
Right arrow Articles by Martines, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brun, P.
Right arrow Articles by Martines, D.

LIVER AND BILIARY TRACT

Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells

Paola Brun,1,2 Ignazio Castagliuolo,1 Massimo Pinzani,3 Giorgio Palù,1 and Diego Martines2

Departments of 1Histology, Microbiology and Medical Biotechnologies and 2Gastroenterological Sciences, University of Padua, Padua; and 3Institute of Internal Medicine, University of Florence, Florence, Italy

Submitted 3 December 2004 ; accepted in final form 11 April 2005

Activated hepatic stellate cells (HSCs) secrete extracellular matrix components during hepatic fibrosis, but recent studies have shown that HSCs can also release a variety of proinflammatory cytokines. Moreover, bacterial endotoxemia is not only associated with systemic complications in the late stages of liver failure but is also a direct cause of liver damage, activating resident inflammatory cells. In this study, we investigated whether HSCs can respond directly to bacterial cell wall products acquiring a new phenotype. RT-PCR and immunocytochemistry assays were used to show that murine HSCs expressed specific mRNA transcripts and proteins for LPS and lipoteichoic acid (LTA) receptor systems and peptidoglycan recognition proteins. Exposing HSCs to bacterial endotoxins led to phosphorylation of mitogen-activated protein kinase ERK1 and the development of a proinflammatory phenotype. After exposure to LPS, LTA, or N-acetyl muramyl peptide, transforming growth factor-{beta}1, IL-6, and monocyte chemoattractant protein-1 (MCP-1) mRNA specific transcripts and proteins increased significantly in HSCs, as assayed by quantitative real-time RT-PCR and ELISA. These LPS-mediated effects in HSCs were receptor dependent, because LPS-induced ERK1 phosphorylation, IL-6, and MCP-1 mRNA and protein level upregulation were significantly less pronounced in HSCs isolated from C3H/HeJ mice lacking Toll-like receptor 4. In conclusion, our results show that murine HSCs express functional receptors for bacterial endotoxins, and HSCs exposed to bacterial products develop a strong proinflammatory phenotype. We speculate that high levels of bacterial endotoxins in the portal vein may directly induce a proinflammatory phenotype in HSCs that contributes to liver damage.

fibrosis; hepatitis; nonalcoholic liver disease; fibronectin; collagen; toll-like receptors



Address for reprint requests and other correspondence: I. Castagliuolo, Univ. of Padua, School of Pharmacy, Via Gabelli, 63, 35121 Padova, Italy (e-mail: ignazio.castagliuolo{at}unipd.it)




This article has been cited by other articles:


Home page
JCOHome page
A. X. Zhu, D. V. Sahani, D. G. Duda, E. di Tomaso, M. Ancukiewicz, O. A. Catalano, V. Sindhwani, L. S. Blaszkowsky, S. S. Yoon, J. Lahdenranta, et al.
Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
J. Clin. Oncol., June 20, 2009; 27(18): 3027 - 3035.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A Mencin, J Kluwe, and R F Schwabe
Toll-like receptors as targets in chronic liver diseases
Gut, May 1, 2009; 58(5): 704 - 720.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. L. Friedman
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Physiol Rev, January 1, 2008; 88(1): 125 - 172.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. J. Hwa, R. C. Fry, A. Sivaraman, P. T. So, L. D. Samson, D. B. Stolz, and L. G. Griffith
Rat liver sinusoidal endothelial cells survive without exogenous VEGF in 3D perfused co-cultures with hepatocytes
FASEB J, August 1, 2007; 21(10): 2564 - 2579.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
P. Brun, I. Castagliuolo, V. D. Leo, A. Buda, M. Pinzani, G. Palu, and D. Martines
Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis
Am J Physiol Gastrointest Liver Physiol, February 1, 2007; 292(2): G518 - G525.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
P Brun, I Castagliuolo, A R Floreani, A Buda, L Blasone, G Palu, and D Martines
Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region.
Gut, August 1, 2006; 55(8): 1212 - 1212.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.